Pfizer Inc - Net Worth and Insider Trading

Pfizer Inc Net Worth

The estimated net worth of Pfizer Inc is at least $357 Million dollars as of 2024-04-22. Pfizer Inc is the 10% Owner of SpringWorks Therapeutics Inc and owns about 4,593,847 shares of SpringWorks Therapeutics Inc (SWTX) stock worth over $184 Million. Pfizer Inc is the 10% Owner of Allogene Therapeutics Inc and owns about 22,032,040 shares of Allogene Therapeutics Inc (ALLO) stock worth over $76 Million. Pfizer Inc is also the 10% Owner of Rhythm Pharmaceuticals Inc and owns about 1,427,639 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $54 Million. Besides these, Pfizer Inc also holds Pyxis Oncology Inc (PYXS) , Imara Inc (IMRA) , Quince Therapeutics Inc (QNCX) , Neoleukin Therapeutics Inc (NLTX) , ICU Medical Inc (ICUI) . Details can be seen in Pfizer Inc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pfizer Inc has not made any transactions after 2023-03-17 and currently still holds the listed stock(s).

Transaction Summary of Pfizer Inc

To

Pfizer Inc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pfizer Inc owns 22 companies in total, including Quince Therapeutics Inc () , Imara Inc () , and SpringWorks Therapeutics Inc () among others .

Click here to see the complete history of Pfizer Inc’s form 4 insider trades.

Insider Ownership Summary of Pfizer Inc

Ticker Comapny Transaction Date Type of Owner
Quince Therapeutics Inc 2020-06-03 10 percent owner
Imara Inc 2020-03-16 10 percent owner
SpringWorks Therapeutics Inc 2019-09-17 10 percent owner
ICU Medical Inc 2018-11-15 director & 10 percent owner
Allogene Therapeutics Inc 2018-10-15 10 percent owner
Rhythm Pharmaceuticals Inc 2017-10-10 10 percent owner
Synlogic Inc 2015-09-30 10 percent owner
Neoleukin Therapeutics Inc 2015-08-10 10 percent owner
Flexion Therapeutics Inc 2014-02-18 10 percent owner
Eiger BioPharmaceuticals Inc 2014-01-29 10 percent owner
Five Prime Therapeutics Inc 2013-09-17 10 percent owner
Zoetis Inc 2013-06-24 10 percent owner
EyePoint Pharmaceuticals Inc 2007-08-27 10 percent owner
Arqule Inc 2003-12-17 10 percent owner
InSite Vision Inc 2003-04-16 10 percent owner
Viatris Inc 2020-08-06 10 percent owner
Cerevel Therapeutics Holdings Inc 2020-10-27 10 percent owner
BioAtla Inc 2020-12-15 10 percent owner
Pyxis Oncology Inc 2023-03-17 10 percent owner
ORIC Pharmaceuticals Inc 2022-12-23 10 percent owner
Enliven Therapeutics Inc 2020-03-11 10 percent owner
Zura Bio Ltd 2023-03-20 10 percent owner

Pfizer Inc Latest Holdings Summary

Pfizer Inc currently owns a total of 8 stocks. Among these stocks, Pfizer Inc owns 4,593,847 shares of SpringWorks Therapeutics Inc (SWTX) as of September 17, 2019, with a value of $184 Million and a weighting of 51.56%. Pfizer Inc owns 22,032,040 shares of Allogene Therapeutics Inc (ALLO) as of October 15, 2018, with a value of $76 Million and a weighting of 21.42%. Pfizer Inc also owns 1,427,639 shares of Rhythm Pharmaceuticals Inc (RYTM) as of October 10, 2017, with a value of $54 Million and a weighting of 15.2%. The other 5 stocks Pyxis Oncology Inc (PYXS) , Imara Inc (IMRA) , Quince Therapeutics Inc (QNCX) , Neoleukin Therapeutics Inc (NLTX) , ICU Medical Inc (ICUI) have a combined weighting of 11.81% among all his current holdings.

Latest Holdings of Pfizer Inc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SWTX SpringWorks Therapeutics Inc 2019-09-17 4,593,847 40.06 184,029,511
ALLO Allogene Therapeutics Inc 2018-10-15 22,032,040 3.47 76,451,179
RYTM Rhythm Pharmaceuticals Inc 2017-10-10 1,427,639 38.01 54,264,558
PYXS Pyxis Oncology Inc 2023-03-17 7,032,770 4.14 29,115,668
IMRA Imara Inc 2020-03-16 1,557,722 6.32 9,844,803
QNCX Quince Therapeutics Inc 2020-06-03 2,879,973 1.05 3,023,972
NLTX Neoleukin Therapeutics Inc 2015-08-10 48,770 3.49 170,207
ICUI ICU Medical Inc 2018-11-15 0 95.77 0

Holding Weightings of Pfizer Inc


Pfizer Inc Form 4 Trading Tracker

According to the SEC Form 4 filings, Pfizer Inc has made a total of 1 transactions in SpringWorks Therapeutics Inc (SWTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in SpringWorks Therapeutics Inc is the acquisition of 50,000 shares on September 17, 2019, which cost Pfizer Inc around $900,000.

According to the SEC Form 4 filings, Pfizer Inc has made a total of 0 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years. The most-recent trade in Allogene Therapeutics Inc is the acquisition of 55,556 shares on October 15, 2018, which cost Pfizer Inc around $1 Million.

According to the SEC Form 4 filings, Pfizer Inc has made a total of 0 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years. The most-recent trade in Rhythm Pharmaceuticals Inc is the acquisition of 40,000 shares on October 10, 2017, which cost Pfizer Inc around $680,000.

More details on Pfizer Inc's insider transactions can be found in the Insider Trading History of Pfizer Inc table.

Insider Trading History of Pfizer Inc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pfizer Inc Trading Performance

GuruFocus tracks the stock performance after each of Pfizer Inc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pfizer Inc is 30.77%. GuruFocus also compares Pfizer Inc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pfizer Inc within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Pfizer Inc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Pfizer Inc

Average Return

44.85%

Average return per transaction

Outperforming Transactions

57%

4 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.17 30.77 -4.66 44.85 8.06 -14.69
Relative Return to S&P 500(%) 1.54 20.9 -15.11 22.36 -11.4 -27.17

Pfizer Inc Ownership Network

Ownership Network List of Pfizer Inc

No Data

Ownership Network Relation of Pfizer Inc


Pfizer Inc Owned Company Details

What does Quince Therapeutics Inc do?

Who are the key executives at Quince Therapeutics Inc?

Pfizer Inc is the 10 percent owner of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include Chief Scientific Officer Guenter Janhofer , President Charles S. Ryan , and director & Chief Executive Officer Dirk Thye .

Quince Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Pfizer Inc made no insider transaction in Quince Therapeutics Inc (). Other recent insider transactions involving Quince Therapeutics Inc () include a net purchase of 500,436 shares made by David Lamond , a net purchase of 168,000 shares made by Dirk Thye , and a net purchase of 71,762 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,871 shares of Quince Therapeutics Inc () were sold and 748,198 shares were bought by its insiders, resulting in a net purchase of 746,327 shares.

Quince Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Quince Therapeutics Inc Insider Transactions

No Available Data

Pfizer Inc Mailing Address

Above is the net worth, insider trading, and ownership report for Pfizer Inc. You might contact Pfizer Inc via mailing address: 66 Hudson Boulevard East, New York Ny 10001-2192.

Discussions on Pfizer Inc

No discussions yet.